Abstract
Up to 50% of men experience at least one episode of prostatitis.1 Prostatitis is actually four different disorders: nonbacterial prostatitis, prostatodynia, acute bacterial prostatitis, and chronic bacterial prostatitis. The constellation of dysuria, perineal pain, urgency, frequency, and nocturia suggests that one of the prostatitis syndromes is present. If there is a urethral discharge, urethritis is the primary consideration. The symptoms of the prostatitis syndromes are similar, with the exception of acute bacterial prostatitis. The findings on digital examination of the prostate gland are inconsistent and nonspecific. Tenderness is present in some patients, but this finding is seen in a similar proportion of patients without prostate disease.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Fowler J. Prostatitis. In: Gillenwater J, Grayback J, Howards S, Duckett J, editors. Adult and pediatric urology. 3rd ed. St. Louis: Mosby, 1996:1715–45.
Moul J. Prostatitis. Postgrad Med 1993;94(5):191–4.
Neal DE, Moon TD. Use of terazosin in prostatodynia and validation of a symptom score questionnaire. Urology 1994; 43:460–5.
Sanford J, Gilbert D, Sande M. Sanford guide to antimicrobial therapy 1995. Dallas: Antimicrobial Therapy, Inc, 1995.
Madsen F, Bruskewitz M. Clinical manifestations of benign prostatic hyperplasia. Urol Clin North Am 1995;22:291–8.
McConnell, J, Barry MJ, Bruskewitz RC. Clinical practice guideline no. 8: benign prostatic hyperplasia: diagnosis and treatment. Bethesda: US Department of Health and Human Services, 1994:1–225. AHCPR Publ. No. 94–0582.
Hicks R, Cooks J. Managing patients with benign prostatic hyperplasia. Am Fam Physician 1995;52:135–42.
Hollander J, Diokno A. Prostatism, benign prostatic hyperplasia. Urol Clin North Am 1996;23:75–86.
Oesterling J. Benign prostatic hyperplasia, medical and minimally invasive treatment options. N Engl J Med 1995;332: 99–109.
Hill S, Lawrence S, Lepor H. New use for alpha blockers: benign prostatic hyperplasia. Am Fam Physician 1994;49: 1885–8.
Wasson J, Reda D, Bruskewitz R, Elinson J, Keller A, Henderson W. A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. N Engl J Med 1995;332:75–9.
Ruckle HC, Klee GG, Oesterling JE. Prostate-specific antigen: critical issues for the practicing physician. Mayo Clin Proc 1994;69:59–68.
Partin A, Oesterling J. The clinical usefulness of prostate specific antigen: update 1994. J Urol 1994;152:1358–68.
Albertsen P, Fryback D, Storer B, Kolon T, Fine J. Long-term survival among men with conservatively treated localized prostate cancer. JAMA 1995;274:626–31.
Catalona W. Management of cancer of the prostate. N Engl J Med 1994;331:996–1004.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
Cullen, P.T. (1998). Prostate Disease. In: Taylor, R.B., David, A.K., Johnson, T.A., Phillips, D.M., Scherger, J.E. (eds) Family Medicine. Springer, New York, NY. https://doi.org/10.1007/978-1-4757-2947-4_98
Download citation
DOI: https://doi.org/10.1007/978-1-4757-2947-4_98
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4757-2949-8
Online ISBN: 978-1-4757-2947-4
eBook Packages: Springer Book Archive